Dr. Kongjia Luo 罗孔嘉
Chief Physician
Department of Thoracic Surgery, Sun Yat-sen University Cancer Center, Guangzhou
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Diagnosis and comprehensive treatment of esophageal cancer, benign esophageal tumors, lung cancer, and pleural diseases using thoracic surgery, digestive endoscopy, and respiratory endoscopy.
Dr. Luo holds a PhD in Oncology from Sun Yat-sen University Cancer Center. The doctor was among the first in China to develop electromagnetic navigation bronchoscopy and submucosal tunneling endoscopic techniques. Dr. Luo reported at the OESO conference that endoscopic surgery for early esophageal cancer yields survival outcomes similar to minimally invasive surgery.
Professional roles
- Member, Thoracic Surgery Branch of Chinese Medical Doctor Association
- Member, Oncology Branch of Guangdong Medical Association
- Editor, Annals of Translational Medicine (AME Publishing)
Name order: in Chinese the family name comes first (Luo Kongjia). Papers usually list the name as Kongjia Luo or Luo K.
Selected publications
68 papers on PubMed matched by name and affiliation; 7 as first or senior author since 2016. Most recent first- or senior-author papers:
- Transl Lung Cancer Res, 2026 (senior author): Electromagnetic navigation bronchoscopy-guided three-dimensional conformal microwave ablation for unresectable peripheral high-risk pulmonary nodules: a mid-term assessment with no real-time intraoperative CT/cone-beam computed tomography guidance. PubMed 42870855
- Int J Surg, 2026 (senior author): Integrative multi-omics identifies endoplasmic reticulum stress-related prognostic biomarkers and CD99-mediated cell-cell communication in lung adenocarcinoma. PubMed 41342545
- Ther Adv Respir Dis, 2024 (senior author): Diagnostic yield using electromagnetic navigation bronchoscopy for peripheral pulmonary nodules <2 cm. PubMed 38757612
- Clin Drug Investig, 2023 (senior author): Tislelizumab Plus Chemotherapy Versus Placebo Plus Chemotherapy as First-Line Treatment for Chinese Patients with Advanced Esophageal Squamous Cell Carcinoma: A Cost-Effectiveness Analysis. PubMed 37542611
- Front Oncol, 2021 (senior author): An Approach to Accelerate Healing and Shorten the Hospital Stay of Patients With Anastomotic Leakage After Esophagectomy: An Explorative Study of Systematic Endoscopic Intervention. PubMed 34079758
- Ann Surg Oncol, 2017 (senior author): Similar Significance of Lymphovascular Invasion with Different Treatment Modalities Among Esophageal Squamous Cell Carcinoma. PubMed 29058142
- Eur J Cardiothorac Surg, 2017 (first author): Localization of peripheral pulmonary lesions to aid surgical resection: a novel approach for electromagnetic navigation bronchoscopic dye marking. PubMed 28459951
- J Surg Oncol, 2011 (first author): CyclinD1, p53, E-cadherin, and VEGF discordant expression in paired regional metastatic lymph nodes of esophageal squamous cell carcinoma: a tissue array analysis. PubMed 21480261
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion